Cell membrane-camouflaged inorganic nanoparticles for cancer therapy

• Published in: Journal of nanobiotechnology Vol. 20; no. 1; pp. 1 - 289
• Main Authors: Song, Wanli, Jia, Pengfei, Zhang, Ting, Dou, Keke, Liu, Lubin, Ren, Yaping, Liu, Fujun, Xue, Junmiao, Hasanin, Mohamed Sayed, Qi, Hongzhao, Zhou, Qihui
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 18.06.2022; BioMed Central; BMC
• Subjects: Active targeting; Analysis; Bibliometrics; Biocompatibility; Blood; Cancer; Cancer therapies; Cancer therapy; Care and treatment; Cell membrane; Cell membranes; Chemotherapy; Cholesterol; Drug delivery; Drug delivery systems; Drugs; Gene transfer; Health aspects; Immune system; Inorganic nanoparticles; Ligands; Melanoma; Membranes; Methods; Multifunction nanoplatform; Nanoparticles; Patient outcomes; Photochemotherapy; Photodynamic therapy; Polyethylene glycol; Proteins; Review; Skin cancer; Toxicity; Tumors; Vehicles; Egypt
• ISSN: 1477-3155; 1477-3155
• DOI: 10.1186/s12951-022-01475-w

Inorganic nanoparticles (INPs) have been paid great attention in the field of oncology in recent past years since they have enormous potential in drug delivery, gene delivery, photodynamic therapy (PDT), photothermal therapy (PTT), bio-imaging, driven motion, etc. To overcome the innate limitations of the conventional INPs, such as fast elimination by the immune system, low accumulation in tumor sites, and severe toxicity to the organism, great efforts have recently been made to modify naked INPs, facilitating their clinical application. Taking inspiration from nature, considerable researchers have exploited cell membrane-camouflaged INPs (CMCINPs) by coating various cell membranes onto INPs. CMCINPs naturally inherit the surface adhesive molecules, receptors, and functional proteins from the original cell membrane, making them versatile as the natural cells. In order to give a timely and representative review on this rapidly developing research subject, we highlighted recent advances in CMCINPs with superior unique merits of various INPs and natural cell membranes for cancer therapy applications. The opportunity and obstacles of CMCINPs for clinical translation were also discussed. The review is expected to assist researchers in better eliciting the effect of CMCINPs for the management of tumors and may catalyze breakthroughs in this area.